CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE

Post-LOE

clotrimazole and betamethasone dipropionate

Teva

ANDATOPICALCREAM

Approved

Oct 2015

Lifecycle

Post-LOE

Competitive Pressure

30/100

Data completeness

3/8 — Basic

CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE (clotrimazole and betamethasone dipropionate) by Teva is [see clinical pharmacology ( error! hyperlink reference not valid. Approved for older for the topical treatment of symptomatic inflammatory tinea pedis, tinea cruris, tinea corporis due to epidermophyton floccosum and 2 more indications. First approved in 2015.

Drug data last refreshed 20h ago

Mechanism of Action

[see Clinical Pharmacology ( Error! Hyperlink reference not valid. )]. Betamethasone dipropionate is a corticosteroid. Corticosteroids play a role in cellular signaling, immune function, inflammation, and protein regulation; however, the precise mechanism of action for the treatment of tinea pedis,…

Pharmacologic Class:

Azole Antifungal

Indications (5)

older for the topical treatment of symptomatic inflammatory tinea pedis tinea cruris

Worked on CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE at Teva? Share your interview experience or compensation data (+7 days Pro)

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.